GB2594792B - Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application - Google Patents

Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application Download PDF

Info

Publication number
GB2594792B
GB2594792B GB2104082.9A GB202104082A GB2594792B GB 2594792 B GB2594792 B GB 2594792B GB 202104082 A GB202104082 A GB 202104082A GB 2594792 B GB2594792 B GB 2594792B
Authority
GB
United Kingdom
Prior art keywords
preparation
preventing
application
novel coronavirus
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB2104082.9A
Other versions
GB2594792A (en
GB202104082D0 (en
Inventor
Cheng Jinsheng
Wan Weihong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaoguan University
Original Assignee
Shaoguan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaoguan University filed Critical Shaoguan University
Publication of GB202104082D0 publication Critical patent/GB202104082D0/en
Publication of GB2594792A publication Critical patent/GB2594792A/en
Application granted granted Critical
Publication of GB2594792B publication Critical patent/GB2594792B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
GB2104082.9A 2020-03-30 2021-03-24 Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application Active GB2594792B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010238228.XA CN111437245A (en) 2020-03-30 2020-03-30 Camellia chrysantha L-theanine oral preparation for preventing novel coronavirus pneumonia and preparation method and application thereof

Publications (3)

Publication Number Publication Date
GB202104082D0 GB202104082D0 (en) 2021-05-05
GB2594792A GB2594792A (en) 2021-11-10
GB2594792B true GB2594792B (en) 2023-09-27

Family

ID=71649306

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2104082.9A Active GB2594792B (en) 2020-03-30 2021-03-24 Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application

Country Status (2)

Country Link
CN (1) CN111437245A (en)
GB (1) GB2594792B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111991414B (en) * 2020-07-30 2023-09-01 福建美拉得康生物制药有限公司 Application of beta-chitosamine in preparing medicament for preventing and treating new coronapneumovirus infection

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008036809A2 (en) * 2006-09-21 2008-03-27 Bukowski, Jack, F. Methods and materials for reducing risk of cold and/or flu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767714B2 (en) * 2002-02-18 2010-08-03 Ajinomoto Co., Inc. Method of preventing infectious diseases
CN1237981C (en) * 2003-12-31 2006-01-25 北京科信必成医药科技发展有限公司 Ginkgoleaf oral cavity disintegrating tablet and its preparation method
CN102525976B (en) * 2011-12-14 2013-05-22 天津药物研究院药业有限责任公司 Method for preparing strontium ranelate orally disintegrating tablets with fluidized bed

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008036809A2 (en) * 2006-09-21 2008-03-27 Bukowski, Jack, F. Methods and materials for reducing risk of cold and/or flu

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Akira Mitsui et al, 9th July 2020, "Elucidation of the antiviral mechanism of mice and comparison with COVID-19 gene set data, bioRxiv, [online], available from: https://www.biorxiv.org/content/10.1101/2020.06.25.149427v2.full.pdf accessed 29th April 2022 *

Also Published As

Publication number Publication date
CN111437245A (en) 2020-07-24
GB2594792A (en) 2021-11-10
GB202104082D0 (en) 2021-05-05

Similar Documents

Publication Publication Date Title
EP4117725A4 (en) Coronavirus vaccine compositions and methods
EP3981400A4 (en) Oral capsule and preparation method therefor
EP3705118A4 (en) Oral solid dosage form composition having improved disintegration and preparation method therefor
EP3952817A4 (en) Hygienic and orthotropic oral devices
EP4048230C0 (en) Oral gliptin compositions and method for preparation thereof
EP3897445A4 (en) Oral mandibular airway device and method
EP3609488A4 (en) Oral microbiota promoting composition and method
EP4034548A4 (en) Coronavirus vaccines and uses thereof
GB202011871D0 (en) Composition and method
GB2594792B (en) Oral Preparation for Preventing the Novel Coronavirus and Preparation Method and Application
IL289586A (en) Micromolecule pi4kiiialpha inhibitor composition, preparation method therefor and use thereof
EP4062906A4 (en) Oral pharmaceutical composition comprising carbamate compound and preparation method therefor
EP4060022A4 (en) Tonsilar organoid preparation method and use thereof
EP4026566A4 (en) Oral pharmaceutical composition comprising teriparatide and method for preparing same
EP4082514A4 (en) Paste-like composition for dental use, and method for producing the same
EP4137124A4 (en) Solid pharmaceutical preparation, preparation method therefor and use thereof
EP4071170A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
EP4269388A4 (en) Dipyrromethene-1-one compound and preparation method therefor
EP4074304A4 (en) Fulvestrant pharmaceutical composition, preparation method therefor, and application thereof
EP3937830C0 (en) Dental splint and method for producing same
EP4082512A4 (en) Dental impression material and combined impression material
EP4039678A4 (en) Compound and preparation method therefor and use thereof
EP3995136A4 (en) Pharmaceutical composition containing tamsulosin or hydrochloride thereof and preparation method therefor
GB2579687B (en) Composition and method
GB201914777D0 (en) Composition and method